Specialisation
James is the leader of our Public M&A and Equity Capital Markets practice. He is a current member of the Australian Takeovers Panel and has extensive experience working in top-tier corporate law firms in Australia and London, on complex public and private M&A and capital raising transactions.
James’ experience includes leading the Kain teams advising:
- SILK Laser Clinics (ASX:SLA) on its acquisition by Australian Pharmaceutical Industries (API) (a subsidiary of Wesfarmers (ASX:WES)) by way of scheme of arrangement for approximately $180 million;
- Symphony Infrastructure Partners on its $488 million Series-A financing round, and on its acquisitions of RJE Global, Catalpa Group, Energy3 and Clutch;
- Kelsian Group (ASX:KLS) on its US$325 million (~A$487 million) acquisition of All Aboard America! Holdings Inc. and the associated A$281 million capital raising;
- Waveconn on its acquisition of AT Australia from American Tower Corporation (NYSE:AMT) and the acquisition of a significant portfolio of mobile tower and rooftop sites from Optus;
- Kelsian Group (ASX:KLS) on its $698 million (including up to $63 million contingent consideration) acquisition of Transit Systems Group, together with a $154 million capital raise by accelerated non-renounceable entitlement offer and placement;
- ROC Partners on its $350 million+ competitive takeover bid for Vitalharvest (ASX:VTH);
- Kelsian Group (ASX:KLS) on its $125 million acquisition of Transit Systems Marine, and the associated capital raising of $51 million, and on Kelsian’s acquisition of the Kingfisher Bay Resort Group for $43 million;
- Ellex Medical Lasers Limited (ASX:ELX) on its capital raising of $23.2 million from US and Australian institutional and sophisticated investors;
- Alcidion Group Limited (ASX:ALC) on its acquisition of MKM Health and UK-based Patientrack; and
- Stilmark Group on its bid for the Optus tower portfolio and on the sale of Stilmark to OMERS Infrastructure.
James is recognised as a leading M&A and Equity Capital Markets lawyer. He has been named ‘Lawyer of the Year’ in the areas of M&A and Equity Capital Markets by Best Lawyers in Australia, was recently named as a ‘Recommended Lawyer’ in the Legal 500 2024 Asia Pacific Edition in the area of Corporate M&A and is listed in the 2024 Doyle’s Guide as a ‘Leading Lawyer’ in the Corporate M&A category.